Price Alert

Stereotaxis Inc. (STXS)

AMEX: STXS · Real-Time Price · USD

2.90

0.20 (7.41%)

At close: Aug 14, 2025, 3:59 PM

2.94

1.20%

Pre-market: Aug 15, 2025, 08:47 AM EDT

7.41% (1D)

Bid	2.85
Market Cap	262.18M
Revenue (ttm)	27.51M
Net Income (ttm)	-25.68M
EPS (ttm)	-0.29
PE Ratio (ttm)	-10.02
Forward PE	-14.59
Analyst	Strong Buy

Ask	2.96
Volume	1,095,926
Avg. Volume (20D)	422,522
Open	2.70
Previous Close	2.70
Day's Range	2.70 - 2.96
52-Week Range	1.54 - 2.96
Beta	1.51

About STXS

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol STXS

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for STXS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

Stereotaxis has released their quartely earnings on Aug 7, 2025:

Revenue of $8.8M exceeds estimates by $743K, with 95.42% YoY growth.

EPS of -0.05 exceeds estimates by 0.02, with 28.57% YoY growth.

Next Earnings Release

Stereotaxis Inc. is scheduled to release its earnings on Nov 10, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

2 weeks ago

+15.11%

Stereotaxis shares are trading higher after the co... Unlock content with Pro Subscription

4 weeks ago

-0.42%

Stereotaxis shares are trading lower after the company announced a $12.5 million registered direct offering.

News

1 week ago · seekingalpha.com

Stereotaxis, Inc. (STXS) Q2 2025 Earnings Call Transcript

Stereotaxis, Inc. (NYSE:STXS ) Q2 2025 Earnings Conference Call August 7, 2025 4:30 PM ET Company Participants David Leo Fischel - CEO & Chairman Kimberly R. Peery - Chief Financial Officer Conference...

1 week ago · zacks.com

Stereotaxis Inc. (STXS) Reports Q2 Loss, Tops Revenue Estimates

Stereotaxis Inc. (STXS) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to a loss of $0.07 per share a year ago.

2 weeks ago · zacks.com

Will Stereotaxis Inc. (STXS) Report Negative Earnings Next Week? What You Should Know

Stereotaxis (STXS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 month ago · zacks.com

Stereotaxis Reports Positive Initial Data From MAGiC Catheter Trial

STXS posts first peer-reviewed results for its MAGiC catheter, showing 94% efficacy and strong safety in arrhythmia treatment.

1 month ago · seekingalpha.com

Stereotaxis: Recurring Revenue Inflection

I rate Stereotaxis Strong Buy, with 85% upside to $4 PT, driven by underappreciated recurring revenue and regulatory catalysts. Recurring revenue is inflecting above 25% growth, with high-margin dispo...